[Quantitative evaluation of the dynamics of tubercular mediastinal adenopathy treated with rifampicin and ethambutol]. 1977

S Tonceanu, and E Bazacliu, and G Carp, and P Varadi, and S Ritter, and F Simon

The authors have followed for one year the rhythm of involution of adenopathy in 114 patients aged between 0 and 16 years, with patent primary infection, in which four therapeutic regimens have been randomly applied, in continuous or intermittent administration, with INH-RMP; RMP-EMB; INH-EMB; INH-SM. Quantified data were obtained with the aid of a planimeter, measuring the surface of the adenopathy on trimestrial seriotomographies. The rhythm of involution was evaluated by the variable halving time of the surface of the adenopathy under treatment. The percentage, the data of the physical model, showed that in the first 3--4 months, detection of the curves is more rapid for RMP and the 7/7 formula, but with almost similar results (8--14%) at 12 months. By processing the data in the computer, depending on the mathematical model, it was estimated that the halving time is by 90,4 days shorter for RMP and similar for EMB and SM.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008477 Mediastinal Diseases Disorders of the mediastinum, general or unspecified. Disease, Mediastinal,Diseases, Mediastinal,Mediastinal Disease
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

S Tonceanu, and E Bazacliu, and G Carp, and P Varadi, and S Ritter, and F Simon
May 1971, Klinicheskaia meditsina,
S Tonceanu, and E Bazacliu, and G Carp, and P Varadi, and S Ritter, and F Simon
March 1980, La Radiologia medica,
S Tonceanu, and E Bazacliu, and G Carp, and P Varadi, and S Ritter, and F Simon
August 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
S Tonceanu, and E Bazacliu, and G Carp, and P Varadi, and S Ritter, and F Simon
January 1971, Problemy tuberkuleza,
S Tonceanu, and E Bazacliu, and G Carp, and P Varadi, and S Ritter, and F Simon
January 2023, Respiratory medicine case reports,
S Tonceanu, and E Bazacliu, and G Carp, and P Varadi, and S Ritter, and F Simon
January 1971, Ftiziologia,
S Tonceanu, and E Bazacliu, and G Carp, and P Varadi, and S Ritter, and F Simon
January 1985, Problemy tuberkuleza,
S Tonceanu, and E Bazacliu, and G Carp, and P Varadi, and S Ritter, and F Simon
May 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
S Tonceanu, and E Bazacliu, and G Carp, and P Varadi, and S Ritter, and F Simon
September 1977, Pneumonologia polska,
S Tonceanu, and E Bazacliu, and G Carp, and P Varadi, and S Ritter, and F Simon
August 2011, Gastrointestinal endoscopy,
Copied contents to your clipboard!